世界における幹細胞移植(腫瘍内科)のパイプライン分析2015

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELV51105)
◆英語タイトル:Stem Cells Transplantation in Oncology -Pipeline Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DELV51105
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆ページ数:※お問い合わせください。
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single User USD1,450 ⇒換算¥163,850見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,900 ⇒換算¥327,700見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界における幹細胞移植(腫瘍内科)のパイプライン分析2015]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Summary
DelveInsight’s, “Stem Cells Transplantation in Oncology -Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this mode of therapy. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Stem Cells Oncology.
• The Report gives insights on 20+ products with 15+ companies, which are active in this field.
• In depth analysis of pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages.
• Comparative study of drugs under development.
• Therapeutics assessment by monotherapy and combination products and molecule type drug information, drug origin and mode of therapy.
• R&D activities and technologies used along with the pipeline therapies in development.
• Information related to collaborations in Stem Cells Transplantation Industry.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Please note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mode of therapy.


Scope
• A snapshot of the global Stem Cell Transplantation therapy market scenario.
• Coverage of stem cell transplantation therapies under development across the globe
• Competitive landscape of investigational products in Stem Cells Therapy
• Detailed information on product description and related stage of development, the mode of therapy, mechanism of action, licensors & collaborators, development partner and technology information



*** レポート目次(コンテンツ)***

• Stem Cell Overview
• Types of stem cell transplants for treating cancer
• Allogeneic and Autologous Transplant
• Future of Stem Cells Transplantation in Oncology
• Current Market Senario
• Stem Cell Transplantation Analysis
• Stem Cells Therapy – Origin
• Stem Cells Therapy – Mode of Therapy
• Stem Cells Therapy – Technology
• Stem Cell Transplantation in Oncology Overview
• Pipeline Therapeutics
• An Overview of Pipeline Products for Stem Cell Oncology
• Therapeutics under Development by Companies
• Last Stage Products (Phase III and Filed)
• Comparative Analysis
• Drug 1
• Product Description:
• Research and Development
• Mid Stage Products (Phase II)
• Comparative Analysis
• Drug 2
• Product Description
• Research and Development
• Early Stage Products (Phase I and IND)
• Comparative Analysis
• Drug 3
• Product Description
• Research and Development
• Discovery and Pre-clinical stage Products
• Comparative Analysis
• Drug 4
• Product Description
• Research and Development
• Therapeutic Assessment
• Assessment by Monotherapy Products
• Assessment by Route of Administration
• Assessment by Source of Stem Cells
• Assessment by Mode of Therapy
• Assessment by Drug Origin
• Discontinued Products
• Dormant Products
• Methodology
• Consulting Services
• About DelveInsight
• Contact Us
• Disclaimer

List of Tables
Table 1: Companies with Stem cells Technology, 2015
Table 2: Stem Cell Therapies Developed using Technology, 2015
Table 3: Total Number of Stem Cells, 2015
Table 4: Number of Products under Development for Stem Cell Oncology, 2015
Table 5: Number of Products under Development by Companies, 2015
Table 6: Last Stage Products (Phase III and Filed), 2015
Table 7: Mid Stage Products (Phase II), 2015
Table 8: Early Stage Products (Phase I and IND), 2015
Table 9: Discovery and Pre-clinical Stage Products, 2015
Table 10: Assessment by Monotherapy Products, 2015
Table 11: Assessment by Route of Administration, 2015
Table 12: Assessment by Stage and Route of Administration, 2015
Table 13: Assessment by Source of stem Cell, 2015
Table 14: Assessment by Mode of Therapy, 2015
Table 15: Assessment by Stage and Mode of Therapy, 2015
Table 16: Assessment by Drug Origin, 2015
Table 17: Assessment by Stage and Drug Origin, 2015
Table 18: Discontinued Products, 2015
Table 19: Dormant Products, 2015



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELV51105 )"世界における幹細胞移植(腫瘍内科)のパイプライン分析2015" (英文:Stem Cells Transplantation in Oncology -Pipeline Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。